Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1138549-36-6
Formula :	C₂₇H₂₇N₇O₂S
M.W :	513.61
SMILES Code :	O=C(C1=C(SC2=CC=CC=C23)N3C4=C(C=CC(N5CCN(C)CCC5)=N4)C1=O)NCC6=NC=C(C)N=C6
Synonyms :	Pidnarulex
MDL No. :	MFCD21609261
InChI Key :	XGPBJCHFROADCK-UHFFFAOYSA-N
Pubchem ID :	25257557

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

HCT116 BRCA2 knockout cells	10^-8 M	48 h	CX-5461 significantly induced more chromosomal abnormalities in BRCA2 knockout HCT116 cells	PMC5321743
U2OS cells	10^-7 M	24 h	CX-5461 robustly induced γ-H2AX and 53BP1 DNA damage foci in U2OS cells	PMC5321743
OVCAR3	12 nM	48 h	To evaluate the growth inhibitory effect of CX-5461 on OVCAR3 cells, results showed that CX-5461 inhibited 50% of cell proliferation at 12 nM concentration.	PMC7251123
OVCAR8	10 nM and 100 nM		To evaluate the growth inhibitory effect of CX-5461 on HR-deficient OVCAR8 cells, results showed increased sensitivity to CX-5461 at 10 nM and 100 nM concentrations.	PMC7251123
human pulmonary arterial smooth muscle cells	2 μM	24 h	CX-5461 induced cell cycle arrest at G1/S phase, reducing the number of cells in S phase, indicating its anti-proliferative effect.	PMC9328314
CHP-134	0.04 µM	3 days	Determine the selective activity of CX-5461 in neuroblastoma cells	PMC8578635
IMR-5	0.05 µM	48 h	Assess the apoptosis-inducing effect of CX-5461 in neuroblastoma cells	PMC8578635
HeLa cells	2 µM	2 h	To investigate the effect of CX-5461 on nucleolar H2BS14p in undamaged cells, results showed that phosphorylation of H2B was undetectable in the presence of the inhibitor.	PMC6068430
LS174t cells	500 nM	24 h	Significantly reduced rDNA transcription, decreased 45S pre-RNA expression	PMC9348601
HCT116 cells	500 nM	72 h	Significantly reduced cell viability, IC50 value of 0.05 µM	PMC9348601
DLD1 cells	500 nM	72 h	Significantly reduced cell viability, IC50 value of 0.49 µM	PMC9348601
HT29 cells	500 nM	72 h	Significantly reduced cell viability, IC50 value of 0.43 µM	PMC9348601
SW480 cells	500 nM	72 h	Significantly reduced cell viability, IC50 value of 0.55 µM	PMC9348601
OVCAR3	12 nM	48 h	To evaluate the growth inhibitory effect of CX-5461 on OVCAR3 cells, results showed that CX-5461 at 12 nM concentration inhibited 50% of cell proliferation.	PMC7251123
OVCAR4	80 nM	48 h	To evaluate the synergistic effect of CX-5461 with HR gene siRNAs, results showed that CX-5461 and HR gene siRNAs exhibited strong synergistic inhibition in OVCAR4 cells.	PMC7251123
OVCAR8	10 nM and 100 nM		To evaluate the growth inhibitory effect of CX-5461 on HR-deficient OVCAR8 cells, results showed that HR-deficient cells exhibited increased sensitivity to CX-5461 at 10 nM and 100 nM concentrations.	PMC7251123
BCPAP cells	100 nM	24 or 48 h	CX-5461 treatment significantly up-regulated the expression levels of PAX8, DIO1, THRA, THRB, FOXE1, and TSHR in BCPAP cells.	PMC10468137
K1 cells	100 nM	24 or 48 h	CX-5461 treatment significantly up-regulated the expression levels of PAX8, DIO1, THRA, THRB, FOXE1, and TSHR in K1 cells.	PMC10468137
SW1736 cells	100 nM	24 or 48 h	CX-5461 treatment significantly up-regulated the expression levels of PAX8, DIO1, THRA, THRB, FOXE1, and TSHR in SW1736 cells.	PMC10468137

mice	BRCA2 knockout tumour model	oral	50 mg/kg	once every three days for 10–20 days	CX-5461 substantially and significantly inhibited the growth rate of tumours formed from BRCA2 knockout HCT116 cells and greatly extended the survival time of the mice	PMC5321743
Mice	HGSOC-PDX model	Oral gavage (CX-5461) and intraperitoneal injection (olaparib)	40 mg/kg	CX-5461 twice a week for 3 weeks; olaparib once daily for 3 weeks	To evaluate the therapeutic efficacy of CX-5461 in combination with PARPi in the HGSOC-PDX model, results showed that the combination of CX-5461 and olaparib significantly prolonged survival and resulted in significant tumor volume reduction.	PMC7251123
Sprague-Dawley rats	monocrotaline (MCT) or Sugen/hypoxia (Su/H) induced pulmonary arterial hypertension model	oral	12.5 mg/kg or 25 mg/kg	every 72 hours for 28 or 56 days	CX-5461 prevented the development of pulmonary arterial remodelling, perivascular inflammation, pulmonary hypertension, and improved survival. Moreover, CX-5461 partly reversed established pulmonary hypertension.	PMC9328314
mice	orthotopic patient-derived xenograft neuroblastoma mouse models	IP injection	5 mg/kg	once daily for 5 days	Evaluate the anti-tumor activity of CX-5461 in vivo	PMC8578635
Mice	CRC xenograft model	Oral	50 mg/kg	Once daily until tumor volume reached 600 mm³	Significantly inhibited tumor growth, reduced Ki67-positive cells, increased necrotic area	PMC9348601
Mice	HGSOC-PDX model	Oral gavage and intraperitoneal injection	40 mg/kg	CX-5461 twice a week, olaparib once daily, for 3 weeks	To evaluate the combined therapeutic effect of CX-5461 and PARPi in the HGSOC-PDX model, results showed that the combination of CX-5461 and olaparib significantly prolonged survival and resulted in significant tumor volume reduction.	PMC7251123
Mice	BCPAP, OCM1, and 611BTPC subcutaneous tumor models	Oral	50 mg/kg	Twice a week, until tumors reached 600 mm³	CX-5461 effectively inhibited tumor growth in BCPAP, OCM1, and 611BTPC subcutaneous tumor models and showed no or mild loss in the mice tested.	PMC10468137

{[proInfo.proName]}

CAS No.: 1138549-36-6

{[proInfo.proName]}

CAS No.: 1138549-36-6

Alternative Products

Product Details of CX-5461

Safety of CX-5461

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	1.95mL 0.39mL 0.19mL	9.74mL 1.95mL 0.97mL	19.47mL 3.89mL 1.95mL
Dissolving Methods	Animal experiment The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed